Goldman Sachs chief credit strategist Lotfi Karoui departs after 18 years - Bloomberg
Saba Capital Management, L.P., a ten-percent owner of abrdn Life Sciences Investors NASDAQ:HQL, a $408 million market cap investment company with an impressive 11.9% dividend yield, sold 48,612 shares of common stock on September 19 and September 22, 2025. According to InvestingPro, HQL has maintained dividend payments for 30 consecutive years. The sales were executed at a price range of $14.1 to $14.14, netting a total of $687094. The stock has shown strong momentum with an 18.8% year-to-date return and maintains a defensive beta of 0.72. Following these transactions, Saba Capital Management, L.P. indirectly owns 2,837,633 shares of abrdn Life Sciences Investors. For more detailed insights and analysis, including 4 additional ProTips, visit InvestingPro.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.